DILIP BUILDCON share price has plunged 5% and is presently trading at Rs 453.9.
Meanwhile, the BSE REALTY index is at 7,421.6 (up 1.4%).
Among the top losers in the BSE REALTY index today is MAHINDRA LIFESPACE (down 1.3%).
OBEROI REALTY (up 3.0%) and DLF (up 1.5%) are among the top gainers today.
Over the last one year, DILIP BUILDCON has moved up from Rs 375.8 to Rs 453.9, registering a gain of Rs 78.1 (up 20.8%).
On the other hand, the BSE REALTY index has moved up from 5,271.5 to 7,421.6, registering a gain of 40.8% during the last 12 months.
The top gainers among the BSE REALTY index stocks during this same period were Sobha (up 91.8%), PRESTIGE ESTATES (up 76.3%) and OBEROI REALTY (up 57.0%).
For Investors: Our Big Prediction
The BSE Sensex is at 77,517.4 (down 0.2%).
The top losers among the BSE Sensex today are ITC (down 2.1%) and Hindustan Unilever (down 2.0%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.
In the meantime, NSE Nifty is at 23,527.8 (down 0.1%). BPCL and ITC are among the top losers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 65,259.5 to 77,517.4, registering a gain of 12,257.9 points (up 18.8%).
DILIP BUILDCON net profit grew 1035.5% YoY to Rs 1,398 million for the quarter ended June 2024, compared to a profit of Rs 123 million a year ago. Net sales rose 7.3% to Rs 31,342 million during the period as against Rs 29,208 million in April-June 2023.
For the year ended March 2024, DILIP BUILDCON reported 14538.5% increase in net profit to Rs 2,010 million compared to net loss of Rs 14 million during FY23. Revenue of the company grew 12.9% to Rs 120,119 million during FY24.
The current Price to earnings ratio of DILIP BUILDCON, based on rolling 12 month earnings, stands at 20.2.
Equitymaster requests your view! Post a comment on "DILIP BUILDCON Plunges 5%; BSE REALTY Index Up 1.4%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!